Invasive Prostate Carcinoma — Trials

Invasive Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

440 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 139
Recruiting: 65
Ph III recruiting: 5
Growth YoY: —
Industry share: 4%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06982222	Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones	withdrawn	Phase 1	0	National Cancer Institute (NCI)NIH	0	Aug 28, 2026	clinicaltrials
NCT06094842	Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer	withdrawn	Phase 1	0	Fred Hutchinson Cancer CenterOTHER	1	Apr 1, 2025